Discovery Bioanalytics
Discovery Bioanalytics develops next-generation analytical tools, including functional filter papers, paper-based lab-on-a-chip devices, and bespoke high-throughput screening assays, to enable faster, greener, and more precise biological insights. Their phosphocellulose cation exchange paper matches the performance of discontinued Whatman P81 paper for radiometric kinase assays, offering direct readout, high sensitivity, and low background in a sustainable format.
- Biotechnology
- New Materials
- Drug Discovery & Therapeutics
- Chemical Technology
- Hardware
Funding
Founders
Founder details are not available yet.
Product
Problem
Conventional biochemical assays are time-intensive, low-throughput, incompatible with automation systems, and cost-prohibitive to scale. High-throughput technologies are often limited to specific analytes, single readouts, and cannot handle complex mixtures, constraining researchers' ability to obtain precise biological data efficiently.
Solution
Discovery Bioanalytics develops next-generation analytical tools and methodologies, from functional filter papers and paper-based lab-on-a-chip devices to bespoke high-throughput screening assays. Their platform integrates custom-made materials, smart manufacturing methods, and bespoke assay development to support a wide range of research and diagnostic applications. The company's phosphocellulose cation exchange paper matches the performance of discontinued Whatman P81 paper and is optimized for radiometric kinase assays, offering direct readout, high sensitivity, and low background. Their functional filter papers enable capture, wash, probe, and quantification using a standard plate reader, simplifying workflows while reducing assay time and costs.
Target Audience
Primary customers are scientists, research teams, and industry partners in pharmaceutical and biotechnology sectors seeking high-throughput screening solutions for biological discovery and therapeutic development.
Features
- Phosphocellulose cation exchange paper that matches the performance of discontinued Whatman P81 paper with superior tensile strength and green manufacturing
- Available in A4 sheets, 96-well filter microplates, filtermats, and custom microplate formats
- Functional filter papers customizable with proteins, antibodies, chemical functional groups, and other modifications for specific assay designs
- 3D-printed plate adaptation integrating functional papers into plate format for high-throughput analysis in any instrument
- Bespoke screening assays designed for specific biological targets with precision capture and purification from complex mixtures
- Paper-based lab-on-a-chip devices enabling orthogonal analysis and quantification of 10-100s of target engagements in real-time